recombinant human kallikrein 1 (Shanghai Wanxing)

重组人激肽释放酶-1

Report date: 2022/03/17 14:03:51

Base Information

Drug Namerecombinant human kallikrein 1 (Shanghai Wanxing)
Drug Alias NameKLK-1rhK-1
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionKallikrein-1 stimulants
TargetsKallikrein-1
Therapy Area/IndicationsCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShanghai Wanxing Biological Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Wanxing Biological Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A